Loading clinical trials...
Loading clinical trials...
The CATALYST Study: Catalyzing Access to New Prevention Products to Stop HIV
The CATALYST study is an implementation study that will characterize and assess the implementation of an enhanced service delivery package providing informed choice of pre-exposure prophylaxis (PrEP) products among women at PEPFAR sites in Kenya, Lesotho, South Africa, Uganda, and Zimbabwe.
The overall study goal is to characterize and assess the implementation of an enhanced service delivery package providing informed choice of pre-exposure prophylaxis (PrEP) products among women at U.S. President's Plan for AIDS Relief/U.S. Agency for International Development (PEPFAR/USAID) delivery sites in Kenya, Lesotho, South Africa, Uganda, and Zimbabwe. The study will be conducted in two stages, with currently approved oral PrEP and PrEP rings offered in Stage I, and the addition of CAB PrEP in Stage II after it has been approved by the regulatory authority in each country. The study goal will be accomplished by conducting a mixed-methods implementation study involving several components: 1. Component 1: Prospective cohort study of women at PEPFAR/USAID delivery sites that are delivering HIV PrEP, including daily oral PrEP, monthly PrEP rings, and bimonthly CAB PrEP 1. Descriptive nested cohort study to evaluate the performance characteristics of different HIV testing strategies among participants who initiate CAB PrEP 2. Descriptive nested cohort study to evaluate the feasibility and validity of a prevention effective use (PEU) measure among a subset of PrEP users 2. Component 2: Mixed-methods process evaluation involving implementers and key stakeholders 1. Nested costing study across Lesotho, Uganda, and Zimbabwe study sites 2. Nested qualitative study to understand community acceptance of PrEP and informed choice of PrEP products
Age
15 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Chulaimbo sub-country hospital
Kisumu, Kenya
Migosi Health
Kisumu, Kenya
Likoni Sub-country hospital
Mombasa, Kenya
Tudor sub-country hospital
Mombasa, Kenya
Bar Hostess Empowerment & Support Programme (BHESP) Drop-In Centre
Nairobi, Kenya
Mukuru Public Health Centre
Nairobi, Kenya
Sefika
Maseru, Lesotho
Scott Hospital
Morija, Lesotho
Berea
Teyateyaneng, Lesotho
Phomolong Clinic
Hennenman, South Africa
Start Date
May 30, 2023
Primary Completion Date
January 27, 2025
Completion Date
January 27, 2025
Last Updated
March 13, 2025
6,069
ACTUAL participants
Lead Sponsor
FHI 360
Collaborators
NCT07292792
NCT07002866
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06745947